Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Feb 2024 for Gamida Cell Ltd.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kenneth I. Moch: trading record in brief
Kenneth I. Moch is a declared insider at 2 companies (board member); the most frequent names are Gamida Cell Ltd. and Zynerba Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 3 August 2021 to 31 January 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 February 2024 with a share grant in Gamida Cell Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kenneth I. Moch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
200,000 shares0Ordinary SharesSEC:0001415889-24-002346:0
28,300 shares0Ordinary SharesSEC:0001209191-23-053260:0
27,954 sharesCommon StockSEC:0001140361-23-047725:0
47,824 shares0Common StockSEC:0001062993-23-013667:0
28,300 shares0Ordinary SharesSEC:0001209191-23-008548:0
2,000 shares0Ordinary SharesSEC:0001209191-22-058393:0
23,109 shares0Common StockSEC:0001062993-22-015039:0
5,000 shares0Common StockSEC:0001192482-21-000642:0
8 of 8 declarations
